Daniel Barber
Chief Scientific Officer
Other
Analyst — R&D
CEO
Board Member
COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aquestive Therapeutics, Inc. (AQST) | President and Chief Executive Officer | $659,885 | $3,493,559 |
| 2024 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer | $633,376 | $4,181,472 |
| 2023 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer | $600,000 | $2,416,088 |
| 2022 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer | $541,591 | $1,326,598 |
| 2021 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer Lori J. Braender\ Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | $424,058 | $1,157,103 |
| 2020 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | $410,000 | $840,083 |
| 2019 | Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | $388,846 | $1,195,228 |
Executive changes
Earnings-call appearances
-
Aquestive Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-07
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-09
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-05
Aquestive Therapeutics, Inc. (AQST)